The global cancer therapeutics market size was valued at $98,900 million in 2018 and is estimated to reach at $180,193 million by 2026, registering a CAGR of 7.7% from 2019 to 2026. Cancer therapeutics involves the use and administration of chemotherapy and oncology drugs to treat cancer.
Report Code : A00381 | Pages : 261 | Category : Life Sciences
The global natural killer cells therapeutics market was valued at $1,402 million in 2018, and is projected to reach $5,096 million by 2026, registering a CAGR of 17.4% from 2019 to 2026.
Report Code : A01802 | Pages : 217 | Category : Life Sciences
The global palliative care market size was valued at $11,200 million in 2020, and is projected to reach $25,309 million by 2030, registering a CAGR of 8.4% from ...
Report Code : A05117 | Pages : 208 | Category : Life Sciences
The China oncology drugs market was valued at $6,498.2 million in 2018 and is projected to reach $12,688.7 million by 2026, registering a CAGR of 8.7% from 2019 ...
Report Code : A04505 | Pages : 135 | Category : Life Sciences
The Japan oncology drugs market size was accounted for $9,405 million in 2018, and is expected to reach $14,109 million by 2026, registering a CAGR of 5.2% from 2019 to 2026.
Report Code : A05277 | Pages : 147 | Category : Life Sciences
The global prostate cancer treatment market size was valued at $6,887 million in 2018, and is projected to reach $9,904 million by 2026, registering a CAGR of 4.6% from 2019 to 2026.
Report Code : A02321 | Pages : 188 | Category : Life Sciences
The global engineered T cells market was valued at $9,668.0 million in 2020, and is projected to reach $149,650.6 million by 2030, registering a CAGR of 32.5% from 2021 to 2030.
Report Code : A04187 | Pages : 227 | Category : Life Sciences
The erythropoietin drugs market size was valued at $9,243.12 million in 2020, and is projected to reach $14,414.59 million by 2028, registering a CAGR of 5.7% from 2021 to 2028.
Report Code : A00001 | Pages : 165 | Category : Life Sciences
Antibody Drug Conjugates Market are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. ADC™s are designed to eliminate cancer cells only without harming the ...
Report Code : A01148 | Pages : 152 | Category : Life Sciences
An influenza vaccine is a vaccine designed to protect against the influenza virus, commonly known as the flu, which comes in trivalent or quadrivalent types, used to treat seasonal and pandemic flu. It is based on egg-based and cell-based technology, used for adults and pediatric as well.
Report Code : A01118 | Pages : 217 | Category : Life Sciences
